Variant report

Variant	esv1850810
Chromosome Location	chr6:25405576-25462543
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:275)
CpG islands
(count:307)
Chromatin interactive
region (count:15)
LncRNA
region (count:7)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:275 , 50 per page) page: 1 2 3 4 5 6

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr6:25404958-25405638	GM12878	blood:	n/a	n/a
2	BACH1	chr6:25450009-25450069	H1-hESC	embryonic stem cell:	n/a	n/a
3	BACH1	chr6:25407928-25408301	H1-hESC	embryonic stem cell:	n/a	n/a
4	BCL11A	chr6:25450124-25450323	H1-hESC	embryonic stem cell:	n/a	n/a
5	BCLAF1	chr6:25405013-25405950	GM12878	blood:	n/a	chr6:25405260-25405269 chr6:25405801-25405810
6	BDP1	chr6:25458743-25459038	Hela-S3	cervix:	n/a	n/a
7	BHLHE40	chr6:25458814-25459069	K562	blood:	n/a	n/a
8	CBX3	chr6:25458689-25459169	HCT-116	colon:	n/a	n/a
9	CBX3	chr6:25420160-25420571	HCT-116	colon:	n/a	n/a
10	CEBPB	chr6:25418114-25418395	HepG2	liver:	n/a	n/a
11	CEBPB	chr6:25404965-25405641	GM12878	blood:	n/a	n/a
12	CEBPB	chr6:25433942-25434245	HepG2	liver:	n/a	chr6:25434100-25434111
13	CEBPB	chr6:25454415-25454615	A549	lung:	n/a	n/a
14	CEBPB	chr6:25449172-25449431	H1-hESC	embryonic stem cell:	n/a	n/a
15	CEBPB	chr6:25423365-25423591	HepG2	liver:	n/a	chr6:25423455-25423466
16	CEBPB	chr6:25418219-25418338	Hela-S3	cervix:	n/a	n/a
17	CEBPB	chr6:25418181-25418313	A549	lung:	n/a	n/a
18	CEBPB	chr6:25423451-25423489	IMR90	lung:	n/a	chr6:25423455-25423466
19	CEBPB	chr6:25459799-25460307	HepG2	liver:	n/a	chr6:25460029-25460041 chr6:25460028-25460041 chr6:25460281-25460293 chr6:25460027-25460044
20	CEBPB	chr6:25457747-25458022	ECC-1	luminal epithelium:	n/a	n/a
21	CEBPB	chr6:25459981-25460242	A549	lung:	n/a	chr6:25460029-25460041 chr6:25460028-25460041 chr6:25460027-25460044
22	CEBPB	chr6:25454408-25454697	IMR90	lung:	n/a	n/a
23	CEBPB	chr6:25423386-25423548	A549	lung:	n/a	chr6:25423455-25423466
24	CHD1	chr6:25411787-25412005	GM12878	blood:	n/a	n/a
25	CTCF	chr6:25412900-25413050	HCFaa	heart:	n/a	n/a
26	CTCF	chr6:25446429-25446531	Spleen_OC	spleen:	n/a	n/a
27	CTCF	chr6:25418180-25418330	RPTEC	kidney:	n/a	chr6:25418229-25418238
28	CTCF	chr6:25425080-25425230	Hela-S3	cervix:	n/a	n/a
29	CTCF	chr6:25446400-25446550	HEK293	kidney:	n/a	n/a
30	CTCF	chr6:25454280-25454430	HCFaa	heart:	n/a	n/a
31	CTCF	chr6:25413000-25413150	GM12875	blood:	n/a	n/a
32	CTCF	chr6:25411184-25411208	Lung_OC	lung:	n/a	n/a
33	CTCF	chr6:25425000-25425150	GM12865	blood:	n/a	n/a
34	CTCF	chr6:25425140-25425290	GM12869	blood:	n/a	n/a
35	CTCF	chr6:25424920-25425070	RPTEC	kidney:	n/a	n/a
36	CTCF	chr6:25439380-25439530	WERI-Rb-1	eye:	n/a	n/a
37	CTCF	chr6:25412940-25413090	HEK293	kidney:	n/a	n/a
38	CTCF	chr6:25418120-25418270	GM12869	blood:	n/a	chr6:25418229-25418238
39	CTCF	chr6:25418320-25418470	GM12869	blood:	n/a	n/a
40	CTCF	chr6:25418140-25418290	HEK293	kidney:	n/a	chr6:25418229-25418238
41	CTCF	chr6:25409400-25409550	GM12869	blood:	n/a	n/a
42	CTCF	chr6:25418160-25418310	GM12872	blood:	n/a	chr6:25418229-25418238
43	CTCF	chr6:25425000-25425150	AoAF	blood vessel:	n/a	n/a
44	CTCF	chr6:25431800-25431950	HPF	lung:	n/a	n/a
45	CTCF	chr6:25418080-25418230	HPAF	blood vessel:	n/a	n/a
46	CTCF	chr6:25449207-25449359	NHEK	skin:	n/a	n/a
47	CTCF	chr6:25428045-25428084	GM13976	blood:	n/a	n/a
48	CTCF	chr6:25425020-25425170	GM12872	blood:	n/a	n/a
49	CTCF	chr6:25424980-25425130	HPAF	blood vessel:	n/a	n/a
50	CTCF	chr6:25405860-25406010	GM12869	blood:	n/a	n/a

(count:307 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:25407628-25407678	SKMC	muscle:	n/a
2	chr6:25407628-25407678	HEEpiC	esophagus:	n/a
3	chr6:25407628-25407678	SKMC	muscle:	n/a
4	chr6:25407628-25407678	HEEpiC	esophagus:	n/a
5	chr6:25417079-25417129	GM06990	blood:	n/a
6	chr6:25459934-25459984	NHBE	bronchial:	n/a
7	chr6:25448910-25448960	HCF	heart:	n/a
8	chr6:25459934-25459984	A549	lung:	n/a
9	chr6:25459934-25459984	GM12891	blood:	n/a
10	chr6:25407628-25407678	NHDF-neo	bronchial:	n/a
11	chr6:25459934-25459984	HNPCEpiC	eye:	n/a
12	chr6:25417079-25417129	CMK	blood:	n/a
13	chr6:25408223-25408273	HAEpiC	amniotic membrane:	n/a
14	chr6:25417079-25417129	HMEC	breast:	n/a
15	chr6:25408223-25408273	MCF10A-Er-Src	breast:	n/a
16	chr6:25408223-25408273	AoSMC	blood vessel:	n/a
17	chr6:25407628-25407678	CMK	blood:	n/a
18	chr6:25417079-25417129	NHDF-neo	bronchial:	n/a
19	chr6:25417079-25417129	MCF10A-Er-Src	breast:	n/a
20	chr6:25408223-25408273	Hela-S3	cervix:	n/a
21	chr6:25407628-25407678	AG04450	lung:	fetal
22	chr6:25408223-25408273	ovcar-3	ovarian:	n/a
23	chr6:25408223-25408273	AG10803	skin:	n/a
24	chr6:25407628-25407678	HEK293	kidney:	embryo
25	chr6:25407628-25407678	BJ	skin:	n/a
26	chr6:25407628-25407678	MCF-7	breast:	n/a
27	chr6:25408223-25408273	GM12892	blood:	n/a
28	chr6:25448910-25448960	MCF-7	breast:	n/a
29	chr6:25459934-25459984	Caco-2	colon:	n/a
30	chr6:25459934-25459984	LNCaP	prostate:	n/a
31	chr6:25459934-25459984	PFSK-1	brain:	n/a
32	chr6:25459934-25459984	SK-N-MC	brain:	n/a
33	chr6:25459934-25459984	RPTEC	kidney:	n/a
34	chr6:25459934-25459984	HPAEpiC	pulmonary alveolar:	n/a
35	chr6:25459934-25459984	SAEC	small airway:	n/a
36	chr6:25417079-25417129	PFSK-1	brain:	n/a
37	chr6:25417079-25417129	AG10803	skin:	n/a
38	chr6:25417079-25417129	HIPEpiC	eye:	n/a
39	chr6:25417079-25417129	HEEpiC	esophagus:	n/a
40	chr6:25408223-25408273	PANC-1	pancreas:	n/a
41	chr6:25459934-25459984	IMR90	lung:	fetal
42	chr6:25408223-25408273	SKMC	muscle:	n/a
43	chr6:25448910-25448960	Hepatocyte	liver:	n/a
44	chr6:25417079-25417129	GM12891	blood:	n/a
45	chr6:25459934-25459984	Jurkat	blood:	n/a
46	chr6:25407628-25407678	GM12878	blood:	n/a
47	chr6:25407628-25407678	AG09309	skin:	n/a
48	chr6:25407628-25407678	Caco-2	colon:	n/a
49	chr6:25448910-25448960	HCPEpiC	choroid plexus:	n/a
50	chr6:25417079-25417129	LNCaP	prostate:	n/a

(count:15 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:25461549..25464417-chr6:25470199..25472256,2	K562	blood:
2	chr6:25448709..25450289-chr6:25450958..25453403,2	K562	blood:
3	chr6:25457887..25461292-chr6:25461516..25464637,3	MCF-7	breast:
4	chr6:25457887..25461292-chr6:25461516..25464637,3	MCF-7	breast:
5	chr6:25445547..25447819-chr6:25452379..25454389,2	K562	blood:
6	chr6:25409840..25412613-chr6:25418004..25420137,2	K562	blood:
7	chr6:25441775..25443784-chr6:25446785..25449168,2	K562	blood:
8	chr6:25436570..25438103-chr6:25438301..25439825,2	K562	blood:
9	chr6:25438440..25439978-chr6:25464168..25466361,2	K562	blood:
10	chr6:25441775..25443784-chr6:25446785..25449168,2	K562	blood:
11	chr6:25409840..25412613-chr6:25418004..25420137,2	K562	blood:
12	chr6:25448709..25450289-chr6:25450958..25453403,2	K562	blood:
13	chr6:25436570..25438103-chr6:25438301..25439825,2	K562	blood:
14	chr6:25276183..25279612-chr6:25456332..25458755,3	MCF-7	breast:
15	chr6:25445547..25447819-chr6:25452379..25454389,2	K562	blood:

(count:7 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SCGN-2	chr6:25439997-25440485	NONHSAT108160
2	lnc-SCGN-3	chr6:25409167-25409543	NONHSAT108157
3	lnc-SCGN-3	chr6:25409167-25409837	NONHSAT108158
4	lnc-SCGN-3	chr6:25409588-25409837	NONHSAT108157
5	lnc-CMAHP-7	chr6:25454465-25454740	NONHSAT108161
6	lnc-SCGN-1	chr6:25454469-25454788	NONHSAT108162
7	lnc-CMAHP-7	chr6:25454750-25455074	NONHSAT108161

No data

Variant related genes	Relation type
ENSG00000238322	TF binding region
ENSG00000253017	TF binding region
LRRC16A	TF binding region
ENSG00000238322	CpG island
ENSG00000253017	CpG island
LRRC16A	CpG island
ENSG00000079691	chromatin interactions

Extended variants
information (count: 2211 )
Associated
traits (count: 102 )

Variant overlapped rSNPs/rCNVs (count:2211 , 50 per page) page: 1 2 3 4 5 6 7 ... 45

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs114550235	chr6:25405577-25405578	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs537521093	chr6:25405588-25405589	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs9461163	chr6:25405595-25405596	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
4	rs370888031	chr6:25405615-25405616	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs145274790	chr6:25405621-25405622	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs190372801	chr6:25405629-25405630	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs553297166	chr6:25405662-25405663	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs571716237	chr6:25405664-25405665	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs573153831	chr6:25405674-25405675	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs147645155	chr6:25405682-25405683	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs367590383	chr6:25405698-25405699	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs558699489	chr6:25405721-25405722	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs575412314	chr6:25405727-25405728	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs9467502	chr6:25405877-25405878	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
15	rs149077891	chr6:25405892-25405893	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs142180532	chr6:25405929-25405930	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs559151255	chr6:25405944-25405945	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs181646413	chr6:25405950-25405951	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs542213095	chr6:25405955-25405956	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs17317669	chr6:25406031-25406032	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
21	rs79794948	chr6:25406036-25406037	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs551622397	chr6:25406065-25406066	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs571491728	chr6:25406127-25406128	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs367773229	chr6:25406179-25406180	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs530599594	chr6:25406239-25406240	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs34154004	chr6:25406324-25406325	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs551093649	chr6:25406347-25406348	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs115759674	chr6:25406403-25406404	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs563984350	chr6:25406404-25406405	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs10946773	chr6:25406438-25406439	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
31	rs376987607	chr6:25406443-25406444	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs552903522	chr6:25406482-25406483	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs187646129	chr6:25406483-25406484	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs562518015	chr6:25406558-25406559	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs571086714	chr6:25406575-25406576	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs189361592	chr6:25406603-25406604	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs369455666	chr6:25406612-25406613	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs10946774	chr6:25406633-25406634	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
39	rs12662331	chr6:25406662-25406663	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
40	rs565030701	chr6:25406672-25406673	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs539634864	chr6:25406675-25406676	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs538054482	chr6:25406677-25406678	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs114003317	chr6:25406678-25406679	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs561960672	chr6:25406679-25406680	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs116328532	chr6:25406680-25406681	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs13214013	chr6:25406696-25406697	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
47	rs559361200	chr6:25406710-25406711	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs556976670	chr6:25406733-25406734	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs12662334	chr6:25406734-25406735	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
50	rs545353931	chr6:25406779-25406780	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:102)

Disease	PMID	Source
Colorectal cancer	21297112	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Multiple myeloma	17550852	CNVD
Ewing''s sarcoma	17952124	CNVD
Gastric cancer	16891809	CNVD
Ovarian cancer	21781307	CNVD
Autism	21448237	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17133270	CNVD
Autism	22495311	CNVD
Burkitt''s lymphoma	19759907	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cancer	16790693	CNVD
Breast cancer	22032731	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21785460	CNVD
Retinoblastoma	16790693	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
T-cell lymphomas	19863542	CNVD
Urothelial carcinoma	18382360	CNVD
Lung cancer	19153074	CNVD
Breast cancer	21364760	CNVD
Cancer	21183584	CNVD
Myelofibrosis	22110671	CNVD
Williams-beuren syndrome	16971481	CNVD
Uveal melanoma	20484589	CNVD
small cell lung cancer	20016488	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Renal cell carcinoma	18765545	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Amyotrophic lateral sclerosis	20685689	CNVD

Chromatin state (count:1269 , 50 per page) page: 1 2 3 4 5 6 7 ... 26

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:25377400-25410600	Weak transcription	Gastric	stomach
2	chr6:25397600-25405600	Weak transcription	Stomach Mucosa	stomach
3	chr6:25402200-25406200	Weak transcription	HUES64 Cell Line	embryonic stem cell
4	chr6:25402200-25409600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
5	chr6:25403600-25406000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
6	chr6:25403600-25406400	Enhancers	iPS-15b Cell Line	embryonic stem cell
7	chr6:25403600-25408200	Enhancers	HUES48 Cell Line	embryonic stem cell
8	chr6:25403800-25406000	Enhancers	Brain Substantia Nigra	brain
9	chr6:25403800-25406400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
10	chr6:25403800-25406400	Weak transcription	Spleen	Spleen
11	chr6:25403800-25410600	Weak transcription	Pancreas	Pancrea
12	chr6:25404200-25406000	Enhancers	iPS-20b Cell Line	embryonic stem cell
13	chr6:25404400-25406400	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood
14	chr6:25404400-25406600	Enhancers	Colonic Mucosa	Colon
15	chr6:25404400-25406600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
16	chr6:25404400-25407400	Weak transcription	Cortex derived primary cultured neurospheres	brain
17	chr6:25404400-25407600	Weak transcription	ES-I3 Cell Line	embryonic stem cell
18	chr6:25404400-25410800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
19	chr6:25404600-25406000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
20	chr6:25404800-25405600	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood
21	chr6:25404800-25405600	Active TSS	Thymus	Thymus
22	chr6:25404800-25405800	Enhancers	HUES6 Cell Line	embryonic stem cell
23	chr6:25404800-25405800	Flanking Active TSS	Primary B cells from peripheral blood	blood
24	chr6:25404800-25405800	Flanking Active TSS	Fetal Thymus	thymus
25	chr6:25404800-25406000	Weak transcription	Sigmoid Colon	Sigmoid Colon
26	chr6:25404800-25406600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
27	chr6:25405000-25405600	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
28	chr6:25405000-25405600	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
29	chr6:25405000-25405600	Flanking Active TSS	NHEK	skin
30	chr6:25405000-25405800	Enhancers	Breast Myoepithelial Primary Cells	Breast
31	chr6:25405000-25405800	Flanking Active TSS	Primary monocytes fromperipheralblood	blood
32	chr6:25405000-25405800	Flanking Active TSS	Primary T helper 17 cells PMA-I stimulated	--
33	chr6:25405000-25406000	Flanking Active TSS	Primary hematopoietic stem cells	blood
34	chr6:25405000-25406000	Flanking Active TSS	Primary T killer naive cells fromperipheralblood	blood
35	chr6:25405000-25406000	Flanking Active TSS	Duodenum Mucosa	Duodenum
36	chr6:25405000-25406000	Enhancers	Fetal Intestine Small	intestine
37	chr6:25405000-25406000	Enhancers	Skeletal Muscle Male	skeletal muscle
38	chr6:25405000-25406200	Enhancers	iPS-18 Cell Line	embryonic stem cell
39	chr6:25405000-25406200	Enhancers	Primary neutrophils fromperipheralblood	blood
40	chr6:25405000-25406200	Flanking Active TSS	Primary B cells from cord blood	blood
41	chr6:25405000-25406200	Enhancers	Fetal Intestine Large	intestine
42	chr6:25405000-25406200	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
43	chr6:25405000-25406400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
44	chr6:25405000-25406600	Enhancers	Adipose Nuclei	Adipose
45	chr6:25405200-25405600	Active TSS	Primary T helper memory cells from peripheral blood 1	blood
46	chr6:25405200-25405600	Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
47	chr6:25405200-25405600	Active TSS	GM12878-XiMat	blood
48	chr6:25405200-25405800	Enhancers	H9 Cell Line	embryonic stem cell
49	chr6:25405200-25405800	Active TSS	Primary hematopoietic stem cells short term culture	blood
50	chr6:25405200-25405800	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links